CBIO 1.48 +8%,solid balance sheet,Institutional Ownership 42.23%,11m O/S,about $30m Net assets vs $15m cap. Catalyst Biosciences and CMC Biologics Announce Manufacturing Agreement for Catalyst’s Next-Generation Factor VIIa Product CB 813d http://www.nasdaq.com/press-release/catalyst-biosciences-and-cmc-biologics-announce-manufacturing-agreement-for-catalysts-20160524-00438?platform=hootsuite